Valerie Odegard
2020
In 2020, Valerie Odegard earned a total compensation of $7.2M as President and Chief Scientific Officer at ARS Pharmaceuticals, a 1,624% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $177,912 |
|---|---|
| Option Awards | $6,601,819 |
| Salary | $374,472 |
| Total | $7,154,203 |
Odegard received $6.6M in option awards, accounting for 92% of the total pay in 2020.
Odegard also received $177.9K in non-equity incentive plan and $374.5K in salary.
Rankings
In 2020, Valerie Odegard's compensation ranked 1,356th out of 13,090 executives tracked by ExecPay. In other words, Odegard earned more than 89.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,356 out of 13,090 | 90th |
Division Manufacturing | 495 out of 5,624 | 91st |
Major group Chemicals And Allied Products | 175 out of 2,257 | 92nd |
Industry group Drugs | 150 out of 1,957 | 92nd |
Industry Pharmaceutical Preparations | 107 out of 1,462 | 93rd |
Source: SEC filing on April 22, 2021.
Odegard's colleagues
We found three more compensation records of executives who worked with Valerie Odegard at ARS Pharmaceuticals in 2020.